Get started
AlenCiken

$CANF Signs $42.7 Million Out-Licensing Deal with Ewopharma

Can-Fite Biopharma Ltd Sponsored (AMEX:CANF)  
AlenCiken  
AMEX:CANF   Can-Fite Biopharma Ltd Sponsored
Trend Analysis Chart Patterns Fundamental Analysis biotech biotechnology biotechstocks biotechs biotechstock biotehnology
1
0
trendanalysis chartpattern fundamental biotech biotechnology biotechstocks biotechs biotechstock biotehnology
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma

Swiss Ewopharma to market Piclidenoson and Namodenoson in Central Eastern Europe (CEE)

$2.25 million upfront payment with an additional $40.45 million for regulatory & sales milestones and 17.5% royalties are included

finance.yahoo.com/ne...llion-110000152.html
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.